Position in EOLS
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$61,650
+$24,492 QoQ
Shares Held
15,000
+113.9% QoQ
Ownership
0.023%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in EOLS Over Time
Shares Held
Position Value (USD)
Derivatives in EOLS
reported options exposure · as of Jun 30, 2020CallValue
$38,690
CallShares
7,300
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026OneDigital Investment Advisors LLC holds $3,011,425 across 7 Drug Manufacturers - Specialty & Generic names. EOLS ranks #6 (2.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
|
103,244 | $1,394,826 | |
| 2 | ZTS |
Zoetis Inc.
|
4,585 | $541,992 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
3,502 | $461,353 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
507 | $300,640 | |
| 5 | HLN |
Haleon plc
|
22,522 | $225,445 | |
| 6 | EOLS |
Evolus, Inc.
This page
|
15,000 | $61,650 | |
| 7 | CRON |
Cronos Group Inc.
|
10,167 | $25,519 |
All Filings in EOLS
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $61,650 | 15,000 | Shares | Sole | 2026-05-08 | |
| 2020-06-30 | $37,158 | 7,011 | Shares | Sole | 2020-08-14 | |
| 2020-06-30 | $38,690 | 7,300 | Call | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||